Evidence map›Paper›PMID 32383329›Full record

ArticleEMBO molecular medicine2020

MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders.

Angelisa Frasca, Eleonora Spiombi, Michela Palmieri, Elena Albizzati, Maria Maddalena Valente, Anna Bergo, Barbara Leva, Charlotte Kilstrup-Nielsen, Federico Bianchi, Valerio Di Carlo and 2 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Dysregulated DNA Methylation inInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Convergence of autism proteins at the cilium.bioRxiv : the preprint server for biology · 2025
    Article
  9. Rett Syndrome: Thinking Beyond Brain Borders.Advances in experimental medicine and biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. iScience · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. A Novel Genetic Variant inInternational journal of molecular sciences · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Angelisa Frasca *Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.ORCID 0000-0002-0963-9789
Eleonora Spiombi *Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Michela PalmieriNeuroscience Division, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Elena AlbizzatiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Maria Maddalena ValenteDepartment of Biotechnology and Life Sciences, Centre of Neuroscience, University of Insubria, Busto Arsizio, Italy.
Anna BergoDepartment of Biotechnology and Life Sciences, Centre of Neuroscience, University of Insubria, Busto Arsizio, Italy.
Barbara LevaDepartment of Biotechnology and Life Sciences, Centre of Neuroscience, University of Insubria, Busto Arsizio, Italy.
Charlotte Kilstrup-NielsenDepartment of Biotechnology and Life Sciences, Centre of Neuroscience, University of Insubria, Busto Arsizio, Italy.
Federico BianchiNeuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy.
Valerio Di CarloDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Ferdinando Di CuntoNeuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy.ORCID 0000-0001-9367-6357
Nicoletta LandsbergerDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.ORCID 0000-0003-0820-3155
University of Insubria · ITUniversity of Milan · ITNeuroscience Institute · ITVita-Salute San Raffaele University · IT

Funding

ProRETT Ricerca
6 · The paper itself

Abstract

Mutations in MECP2 cause several neurological disorders of which Rett syndrome (RTT) represents the best-defined condition. Although mainly working as a transcriptional repressor, MeCP2 is a multifunctional protein revealing several activities, the involvement of which in RTT remains obscure. Besides being mainly localized in the nucleus, MeCP2 associates with the centrosome, an organelle from which primary cilia originate. Primary cilia function as "sensory antennae" protruding from most cells, and a link between primary cilia and mental illness has recently been reported. We herein demonstrate that MeCP2 deficiency affects ciliogenesis in cultured cells, including neurons and RTT fibroblasts, and in the mouse brain. Consequently, the cilium-related Sonic Hedgehog pathway, which is essential for brain development and functioning, is impaired. Microtubule instability participates in these phenotypes that can be rescued by HDAC6 inhibition together with the recovery of RTT-related neuronal defects. Our data indicate defects of primary cilium as a novel pathogenic mechanism that by contributing to the clinical features of RTT might impact on proper cerebellum/brain development and functioning, thus providing a novel therapeutic target.

Indexed as

Rett SyndromeAnimalsBrainHedgehog ProteinsHumansMethyl-CpG-Binding Protein 2MiceMutationHedgehog ProteinsMECP2 protein, humanMecp2 protein, mouseMethyl-CpG-Binding Protein 2MeCP2primary ciliumRett syndromesonic hedgehogtubacin treatment

Identifiers

PMID32383329
PMCPMC7278541
OpenAlexW3021594944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.